Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Endocrine 1

Conditions

Prostatic Neoplasms 18Neoplasms 14Breast Neoplasms 13Neuroendocrine Tumors 9Lung Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Neoplasm Metastasis 6Stomach Neoplasms 5Esophageal Neoplasms 5Uterine Cervical Neoplasms 4Pancreatic Neoplasms 4Multiple Myeloma 4Disease 4Urinary Bladder Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Rectal Neoplasms 3Mouth Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma 3Head and Neck Neoplasms 3Glioma 3Esophageal Squamous Cell Carcinoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplastic Cells, Circulating 2Nasopharyngeal Carcinoma 2Multiple Pulmonary Nodules 2Lymphoma, Follicular 2Lymphoma, B-Cell 2Liver Neoplasms 2Leukemia 2

Interventions

Positron Emission Tomography Computed Tomography 13-fluorobenzylguanidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neural crest tumor × Positron Emission Tomography Computed Tomography × Clear all
NCT04258592 2022-08-12

18F-MFBG PET Imaging of the Norepinephrine Transporter in Neural Crest and Neuroendocrine Tumors

Universitaire Ziekenhuizen KU Leuven

Phase 1 Terminated
6 enrolled
EndocrineNET

Neural crest tumor, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡